Unmasking Hidden High-Risk Neuroblastoma: ML-Driven CMBs Refine Conventional Risk Stratification –Two case reports
Background Neuroblastoma (NB) is the most frequent solid cancer of early childhood. Owing to the significant heterogeneity of NB, which results in variation in treatment response and outcomes, the International Neuroblastoma Risk Group (INRG) and Chil
Authors
- Jianfeng Zhou (ORCID: https://orcid.org/0000-0001-5702-6664)
- Qiyang Shen (ORCID: https://orcid.org/0000-0001-8963-1244)
- Xu Wang (ORCID: https://orcid.org/0000-0003-1060-840X)
- Nan Xie (ORCID: https://orcid.org/0000-0002-1972-8187)
- Tao Li (ORCID: https://orcid.org/0009-0006-6811-2182)
- Pan Sirui
Institutions
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Published
- 2025-07-18
- DOI
- https://doi.org/10.22541/au.175282400.05381017/v1
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00